Questions for GSK on Investing in Health Care Workers
May 27, 2011
Commenting on GlaxoSmithKline's announcement this week that it will redistribute a portion of its proceeds back to least developed countries (LDCs) to address the shortage of health care workers, Nandini Oomann, director of the HIV/AIDS Monitor at the Center for Global Development, poses two questions for the company on the center's "Global Health Policy" blog and states that GSK "is in a unique position to combine lessons from the aid industry with its own private sector industrial efficiency and wisdom to lead the way for effective (locally derived and implemented, outcome based) private sector investment in global health and development" (5/25).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)